Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis

BACKGROUND: In 2003, China implemented free antiretroviral therapy (ART) for people living with HIV (PLHIV), establishing an eligibility threshold of CD4 < 200 cells/μl. Subsequently, the entry criteria were revised in 2012 (eligibility threshold: CD4 ≤ 350 cells/μl), 2014 (CD4 ≤ 500 cells/μl), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinsheng, Wu, Guohui, Ma, Ping, Wang, Rugang, Li, Linghua, Sun, Yinghui, Xu, Junjie, Li, Yuwei, Zhang, Tong, Li, Quanmin, Yang, Yuecheng, Wang, Lijing, Xin, Xiaoli, Qiao, Ying, Fang, Bingxue, Lu, Zhen, Zhou, Xinyi, Chen, Yuanyi, Liu, Qi, Fu, Gengfeng, Wei, Hongxia, Huang, Xiaojie, Su, Bin, Wang, Hui, Zou, Huachun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424386/
https://www.ncbi.nlm.nih.gov/pubmed/37580822
http://dx.doi.org/10.1186/s40249-023-01119-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424386/
https://www.ncbi.nlm.nih.gov/pubmed/37580822
http://dx.doi.org/10.1186/s40249-023-01119-7

Ejemplares similares